Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study

W David Strain, Valentina Lukashevich, Wolfgang Kothny, Marie-José Hoellinger, Päivi Maria Paldánius
  • The Lancet, August 2013, Elsevier
  • DOI: 10.1016/s0140-6736(13)60995-2

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/s0140-6736(13)60995-2

The following have contributed to this page: Dr William D Strain